baveno
login become a member
  • About
    • Who we are
    • Mission and aims
    • Statutes
    • Minutes and annual reports
  • Baveno Consensuses
    • Previous Baveno consensuses
    • Baveno VIII
  • Research and Collaborations
    • Rules for endorsement (for members)
    • Rules of publication (for members)
    • Ongoing Studies (for members)
    • Submit a project (for members)
    • Collaborations and links (for members)
    • Register to get access
  • Resources and Events
    • Publications
    • Slides Center
    • Presymposium on Design in Clinical Trials (members)
    • Events
  • Sponsorship
  • Member
    • Register to get access
  • Contact

Author Details

Name: Thomas Reiberger

Affiliations: Division of Gastroenterology and Hepatology, Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria.

Publications

  • Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study.
  • Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.
  • Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis.
  • Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding.
  • Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.
  • Non-invasive tests for clinically significant portal hypertension after HCV cure.
  • Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.
  • Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
  • Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.

Baveno Cooperation

Lacknergasse 13 Apt 7
1170 Vienna
Austria

contact

Endorsed by

easl
  • facebook
Become a sponsor

Baveno Cooperation © 2025

Handcrafted by PixInside s.a.
  • About
    • Who we are
    • Mission and aims
    • Statutes
    • Minutes and annual reports
  • Baveno Consensuses
    • Previous Baveno consensuses
    • Baveno VIII
  • Research and Collaborations
    • Rules for endorsement (for members)
    • Rules of publication (for members)
    • Ongoing Studies (for members)
    • Submit a project (for members)
    • Collaborations and links (for members)
    • Register to get access
  • Resources and Events
    • Publications
    • Slides Center
    • Presymposium on Design in Clinical Trials (members)
    • Events
  • Sponsorship
  • Member
    • Register to get access
  • Contact